Cargando…

Evaluating Bone Loss with Bone Turnover Markers Following Acute Spinal Cord Injury

STUDY DESIGN: Prospective observational study. PURPOSE: To evaluate bone turnover markers (BTMs) in individuals with acute spinal cord injury (SCI) and to compare the results with those of healthy controls and postmenopausal females. OVERVIEW OF LITERATURE: SCI significantly impacts bone health. Cha...

Descripción completa

Detalles Bibliográficos
Autores principales: Thakkar, Prince, Prakash, Naveen B., Tharion, George, Shetty, Sahana, Paul, Thomas V., Bondu, Joseph, Yadav, Bijesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Spine Surgery 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7010505/
https://www.ncbi.nlm.nih.gov/pubmed/31679327
http://dx.doi.org/10.31616/asj.2019.0004
_version_ 1783495887743352832
author Thakkar, Prince
Prakash, Naveen B.
Tharion, George
Shetty, Sahana
Paul, Thomas V.
Bondu, Joseph
Yadav, Bijesh
author_facet Thakkar, Prince
Prakash, Naveen B.
Tharion, George
Shetty, Sahana
Paul, Thomas V.
Bondu, Joseph
Yadav, Bijesh
author_sort Thakkar, Prince
collection PubMed
description STUDY DESIGN: Prospective observational study. PURPOSE: To evaluate bone turnover markers (BTMs) in individuals with acute spinal cord injury (SCI) and to compare the results with those of healthy controls and postmenopausal females. OVERVIEW OF LITERATURE: SCI significantly impacts bone health. Change in bone mineral density appears 6 months after SCI and rapid bone loss during the acute phase is often underestimated, resulting in osteoporosis and a high risk of sublesional fractures. However, few studies have evaluated BTMs in the Indian SCI population. Despite a high risk of fracture, there are no guidelines for the diagnosis, monitoring, and management of SCI-induced osteoporosis. METHODS: Twenty patients within 1 month of traumatic SCI who had been admitted to a tertiary care rehabilitation center were included in this study. Serum BTMs, C telopeptide (CTX) as a bone resorption marker, and osteocalcin as a bone formation marker, were serially measured at baseline, and 3 and 6 months after SCI. BTMs of SCI patients were compared with those of a control group of age-matched healthy males, premenopausal females, and a vulnerable group of postmenopausal females. RESULTS: BTMs were significantly elevated in patients with SCI, with maximum levels observed at the 3rd month of injury. At baseline, the bone resorption marker CTX was approximately 3 times higher in SCI patients than in the control male population and premenopausal females, and about double that of postmenopausal females. The rise in the bone formation marker was marginal in comparison to that of the bone resorption marker. BTMs were persistently elevated and did not reach the normative range until the 6th month of SCI. CONCLUSIONS: Raised bone resorption markers in comparison to bone formation markers indicate hyper-resorption-related bone loss following acute SCI. Markedly elevated bone resorption markers in the SCI population, compared with those in control and vulnerable groups, emphasize the need for early bone health monitoring and management.
format Online
Article
Text
id pubmed-7010505
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Korean Society of Spine Surgery
record_format MEDLINE/PubMed
spelling pubmed-70105052020-02-20 Evaluating Bone Loss with Bone Turnover Markers Following Acute Spinal Cord Injury Thakkar, Prince Prakash, Naveen B. Tharion, George Shetty, Sahana Paul, Thomas V. Bondu, Joseph Yadav, Bijesh Asian Spine J Clinical Study STUDY DESIGN: Prospective observational study. PURPOSE: To evaluate bone turnover markers (BTMs) in individuals with acute spinal cord injury (SCI) and to compare the results with those of healthy controls and postmenopausal females. OVERVIEW OF LITERATURE: SCI significantly impacts bone health. Change in bone mineral density appears 6 months after SCI and rapid bone loss during the acute phase is often underestimated, resulting in osteoporosis and a high risk of sublesional fractures. However, few studies have evaluated BTMs in the Indian SCI population. Despite a high risk of fracture, there are no guidelines for the diagnosis, monitoring, and management of SCI-induced osteoporosis. METHODS: Twenty patients within 1 month of traumatic SCI who had been admitted to a tertiary care rehabilitation center were included in this study. Serum BTMs, C telopeptide (CTX) as a bone resorption marker, and osteocalcin as a bone formation marker, were serially measured at baseline, and 3 and 6 months after SCI. BTMs of SCI patients were compared with those of a control group of age-matched healthy males, premenopausal females, and a vulnerable group of postmenopausal females. RESULTS: BTMs were significantly elevated in patients with SCI, with maximum levels observed at the 3rd month of injury. At baseline, the bone resorption marker CTX was approximately 3 times higher in SCI patients than in the control male population and premenopausal females, and about double that of postmenopausal females. The rise in the bone formation marker was marginal in comparison to that of the bone resorption marker. BTMs were persistently elevated and did not reach the normative range until the 6th month of SCI. CONCLUSIONS: Raised bone resorption markers in comparison to bone formation markers indicate hyper-resorption-related bone loss following acute SCI. Markedly elevated bone resorption markers in the SCI population, compared with those in control and vulnerable groups, emphasize the need for early bone health monitoring and management. Korean Society of Spine Surgery 2020-02 2019-11-05 /pmc/articles/PMC7010505/ /pubmed/31679327 http://dx.doi.org/10.31616/asj.2019.0004 Text en Copyright © 2020 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Study
Thakkar, Prince
Prakash, Naveen B.
Tharion, George
Shetty, Sahana
Paul, Thomas V.
Bondu, Joseph
Yadav, Bijesh
Evaluating Bone Loss with Bone Turnover Markers Following Acute Spinal Cord Injury
title Evaluating Bone Loss with Bone Turnover Markers Following Acute Spinal Cord Injury
title_full Evaluating Bone Loss with Bone Turnover Markers Following Acute Spinal Cord Injury
title_fullStr Evaluating Bone Loss with Bone Turnover Markers Following Acute Spinal Cord Injury
title_full_unstemmed Evaluating Bone Loss with Bone Turnover Markers Following Acute Spinal Cord Injury
title_short Evaluating Bone Loss with Bone Turnover Markers Following Acute Spinal Cord Injury
title_sort evaluating bone loss with bone turnover markers following acute spinal cord injury
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7010505/
https://www.ncbi.nlm.nih.gov/pubmed/31679327
http://dx.doi.org/10.31616/asj.2019.0004
work_keys_str_mv AT thakkarprince evaluatingbonelosswithboneturnovermarkersfollowingacutespinalcordinjury
AT prakashnaveenb evaluatingbonelosswithboneturnovermarkersfollowingacutespinalcordinjury
AT thariongeorge evaluatingbonelosswithboneturnovermarkersfollowingacutespinalcordinjury
AT shettysahana evaluatingbonelosswithboneturnovermarkersfollowingacutespinalcordinjury
AT paulthomasv evaluatingbonelosswithboneturnovermarkersfollowingacutespinalcordinjury
AT bondujoseph evaluatingbonelosswithboneturnovermarkersfollowingacutespinalcordinjury
AT yadavbijesh evaluatingbonelosswithboneturnovermarkersfollowingacutespinalcordinjury